Linezolid versus Vancomycin for Prosthetic Joint Infections: a Cost Analysis

Abstract

Prosthetic joint infections (PJIs) caused by methicillin-resistant gram-positive bacteria are primarily treated by intravenous vancomycin. Linezolid, active against methicillin-resistant strains and available in oral and intravenous dosage forms, is a potential alternative to vancomycin for the treatment of PJIs. To analyze the cost of linezolid therapy… (More)
DOI: 10.1007/s15010-007-6304-8